• Logo
  • SBMUJournals

Photodynamic Therapy – A Non-invasive Treatment Modality for Precancerous Lesions

Kotya Naik Maloth, Nagalaxmi Velpula, Srikanth Kodangal, Mithare Sangmesh, Kiran Vallamchetla, Sridevi Ugrappa, Nagajyothi Meka




Introduction: Oral premalignant lesions are conditions having high potential tendency for transformation into malignancy. The use of a conservative and effective treatment modality is one of the best strategies for cancer prevention. Photodynamic therapy (PDT) is a non-invasive method for topical and selective treatment of oral precancerous lesions. The present study was taken up to determine the efficacy of PDT in oral precancerous lesions.

Methods: The study consisted 13 patients with 24 oral leukoplakia (OL) lesions and 8 with 20 oral lichen planus (OLP) lesions, divided into control and study groups. These lesions were affecting various intraoral sites, the buccal mucosa being the most common site followed by tongue and gingiva. The treatment regimen of PDT included 98% 5–aminolevulinic acid (5-ALA) which is topical applied and irradiated with light emitting diode (LED) of 420 nm wavelengths at several sessions.

Results: In OL 16.6% of cases showed complete response, 66.6% partial response and 16.6% no response of the lesions to the treatment. In OLP 80% and 20% of the lesions showed partial and no response respectively. The differences with control groups for OL + OLP were found to be significant (P < 0.001).

Conclusion: Based on the results of the present study, we can conclude that PDT appears to be a feasible alternative to conventional therapy for oral premalignant lesions.


5-Aminolevlinic acid; Photodynamic therapy; Oral leukoplakia


J. Prognosis of oral pre-malignant lesions: signifi¬cance of clinical, histopathological, and molecular biolog¬ical characteristics. Crit Rev Oral Biol Med. 2003;14(1):47- 62. doi:10.1177/154411130301400105.

Johann AC, Silveira-Junior JB, Souto GR, Horta MC, Agu¬iar MC, Mesquita RA. Metallothionein immune expression in oral leukoplakia. Med Oral Cir Buccal. 2008;13(3):E156- 160.

Ribeiro AS, Ribeiro SL. A review of the nonsurgical treat¬ment of oral leukoplakia. Int J Dent. 2010;2010:186018. doi:10.1155/2010/186018.

Scott SD, Katharine NC. Lichen planus, lichenoid drug reactions, and Lichenoid mucositis. Dent Clin N Amr. 2005;49(1):77-89. doi:10.1016/j.cden.2004.08.004

Mehta FS, Hamner JE III. Tobacco– related oral muco¬sal lesions and conditions in India;a guide for dental stu¬dents, dentists and physicians. Br J Oral Maxillofacial Surg. 1995;33(5):336. doi:10.1016/0266-4356(95)90070-5.

Konopka K, Goslinski T. Photodynamic thera¬py in dentistry. J Dent Res. 2007;86(8):694-707. doi:10.1177/154405910708600803.

Chen HM, Yu CH, Tsai T, Hsu YC, Kuo RC, Chiang CP. Topical 5 - aminolevlinic acid mediated photodynamic therapy for oral verrucous hyperplasia, oral leukoplakia and oral erythroleukoplakia. Photodiagnosis Photodyn Ther. 2007;4:44-52. doi:10.1016/j.pdpdt.2006.11.003.

Axéll T. Occurrence of leukoplakia and some other oral white lesion among 20,333 adult Swedish people. Commu¬nity Dent Oral Epidemiol. 1987;15:46-51.

Lumerman H, Freedman P, Kerpel S. Oral epithelial dys¬plasia and the development of invasive squamous cell car¬cinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995;79(3):321-329.

Scully C. Oral precancer: preventive and medical ap¬proaches to management. Eur J Cancer B Oral Oncol. 1995;31B(1):16-26. doi:10.1016/0964-1955(94)00049-a.

Aghahosseini F, Arbabi–Kalati F, Fashtami LA, Fateh M, Djavid GE. Treatment of oral lichen planus with photo¬dynamic therapy mediated methylene blue; a case report. Med Oral Pathol Oral Cir Buccal. 2006;11:E126-1299. doi:10.1002/lsm.20278.

Jurczyszyn K, Ziółkowski P, Gerber H, Osiecka BJ. Poten¬tiality of photodynamic therapy in dentistry – literature review. Dent Med Probl. 2007;44(2):255-258.

Meyer-Betz F. Investigations on the biological (photody¬namic) action of hematoporphyrin and other derivatives of the blood and bile pigments. Deutsch Arch Klin Med .1913;112:476-503.

Hayata Y, Kato H, Konaka C, Ono J, Takizawa N. Hae¬matoporphyrin derivative and laser photoradiation in the treatment of lung cancer. Chest. 1982;81:269-277.

McGillis ST, Fein H. Topical treatment strategies for non-melanoma skin cancer and precursor lesions. Se¬min Cutan Med Surg. 2004;23:174-183. doi:10.1016/j. sder.2004.06.005.

Rivard J, Ozog D. Henry ford hospital dermatology expe¬rience with levulan kerastick and blue light photodynamic therapy. J Drugs Dermatol. 2006;5(6):556-561.

Kübler AC, Kaus M, Hofele C, Zoller J. Photodynamic ther¬apy of oral leukoplakia by topical application of 5-amino¬levulinic acid (ALA) (abstract). J Craniomaxillofac Surg. 1996;24(1 Suppl):141.

Fan KF, Hopper C, Speight PM, Buonaccorsi G, MacRob¬ert AJ, Bown SG. Photodynamic therapy using 5-amino¬levulinic acid for premalignant and malignant lesions of the oral cavity. Cancer. 1996;78:1374-1383.

Kubler A, Haase T, Rheinwald M, Barth T, Mühling J. Treat¬ment of oral leukoplakia by topical application of 5-amino¬levlinic acid. Int J Oral Maxillofac Surg. 1998;27:466-469. doi:10.1016/s0901-5027(98)80040-4.

Sieron A, Namyslowski G, Misiolek M, Adamek M, Kaw¬czyk-Krupka A. Photodynamic therapy of premalignant lesion and local recurrence of laryngeal and hypopharyn¬geal cancers. Eur Arch Otorhinolaryngol. 2001;258:349-352. doi:10.1016/s0901-5027(98)80040-4.

Sieroń A, Adamek M, Kawczyk-Krupka A, Mazur S, Ile¬wicz L. Photodynamic therapy (PDT) using topically ap¬plied δ-aminolevlinic acid (ALA) for the treatment of oral Leukoplakia. J Oral Pathol Med. 2003;32:330-336. doi:10.1034/j.1600-0714.2003.00068.x.

Tsai JC, Chiang CP, Chen HM, et al. Photodynamic thera¬py of oral dysplasia with topical 5-aminolevulinic acid and light-emitting diode array. Lasers Surg Med. 2004;34:18-24. doi:10.1002/lsm.10250.

Chen HM, Chen CT, Yang H, et al. Successful treatment of oral verrucous hyperplasia with topical 5-aminolevulin¬ic acid-mediated photodynamic therapy. Oral Oncol. 2004;40:630-637. doi:10.1016/j.oraloncology.2003.12.010.

Lin HP, Chen HM, Yu CH, Yang H, Wang YP, Chiang CP. Topical photodynamic therapy is very effective for verrucous hyperplasia and oral erythroleukoplakia. J Oral Pathol Med. 2010;39:624-630. doi:10.1111/j.1600- 0714.2010.00935.x.

Franco R Jr. Photodynamic treatment of larynge¬al leukoplakia with ALA. Otolaryngol Head Neck Surg. 2006;135(2):197-8.

Shafirstein G, Bäumler W, Sigel E, Fan CY, Berry K. Uti¬lizing 5-aminolevulinic acid and pulsed dye laser for pho¬todynamic therapy of oral leukoplakia–pilot study. Head Neck Oncol. 2010;2(Suppl 1):O40. doi:10.1111/j.1600- 0714.2010.00935.x.

Ericson MB, Wennberg AM, Larkö O. Review of photody¬namic therapy in actinic keratosis and basal cell carcinoma. Ther Clin Risk Manag. 2008;4(1):1-9.

Jerjes W, Hamdoon Z, Hopper C. Photodynamic therapy in the management of potentially malignant and malignant oral disorders. Head Neck Oncol. 2012;4(16):1-7.

Chen HM, Yu CH, Tu PC, Yeh CY, Tsai T, Chiang CP. Suc¬cessful treatment of oral verrucous hyperplasia and oral leukoplakia with topical 5-aminolevulinic acid-mediated photodynamic therapy. Lasers Surg Med. 2005;37:114-122. doi:10.1002/lsm.20214.

Kirby B, Whitehurst C, Moore JV, Yates VM. Treatment of lichen planus of the penis with photodynamic therapy. Br J Dermatol. 1999;141:765-766.

Aghahosseini F, Arbabi F, Fashtami LA, Esmaeeli G, Fateh M, Beitollahi JM. Methylene blue - mediated photody¬namic therapy: a possible alternative treatment for oral li¬chen planus. Lasers Surg Med. 2006;38:33-38. doi:10.1002/ lsm.20278.

Sadaksharam J, Nayaki KP, Selvam NP. Treatment of oral lichen planus with methylene blue mediated photody¬namic therapy--a clinical study. Photodermatol Pho�¬toimmunol Photomed. 2012;28(2):97-101. doi:10.1111 /j.1600-0781.2012.00647

DOI: https://doi.org/10.22037/jlms.v7i1.9324